Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal



Proietti, Marco ORCID: 0000-0003-1452-2478 and Boriani, Giuseppe
(2018) Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 14. 1483 - 1488.

[img] Text
Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal.pdf - OA Published Version

Download (963kB) | Preview
Item Type: Article
Uncontrolled Keywords: anticoagulant drugs, non-vitamin K antagonist oral anticoagulants, reversal agents, idarucizumab, major bleeding
Depositing User: Symplectic Admin
Date Deposited: 17 May 2019 10:33
Last Modified: 27 Jan 2022 01:18
DOI: 10.2147/TCRM.S140377
Open Access URL: http://doi.org/10.2147/TCRM.S140377
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3041760